-
1دورية أكاديمية
المصدر: Cancer Management and Research, Vol Volume 16, Pp 491-505 (2024)
مصطلحات موضوعية: nomograms, prognosis, prediction, hr+ her- breast cancer, chemotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Ruth Moulson, Guillaume Feugère, Tracy S. Moreira-Lucas, Florence Dequen, Jessica Weiss, Janet Smith, Christine Brezden-Masley
المصدر: Current Oncology, Vol 31, Iss 4, Pp 2172-2184 (2024)
مصطلحات موضوعية: real-world evidence, CDK4/6 inhibitors, AI, HR+, HER2−, metastatic breast cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Arif Ali Awan, Deanna Saunders, Gregory Pond, Caroline Hamm, Nadia Califaretti, Mihaela Mates, Vikaash Kumar, Mohammed F. K. Ibrahim, Ana-Alicia Beltran-Bless, Lisa Vandermeer, John Hilton, Mark Clemons
المصدر: Current Oncology, Vol 31, Iss 3, Pp 1278-1290 (2024)
مصطلحات موضوعية: PREDICT 2.1, Oncotype DX, early-stage HR+ breast cancer, real-world evidence, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: Elias Obeid, Rohan C. Parikh, Elizabeth Esterberg, Bhakti Arondekar, Abigail Hitchens, Lillian Shahied Arruda, Alexander Niyazov, Kristen Whitaker
المصدر: Frontiers in Oncology, Vol 14 (2024)
مصطلحات موضوعية: metastatic breast cancer, BRCA1/2 gene mutations, poly (ADP-ribose) polymerase (PARP) inhibitors, human epidermal growth factor receptor 2 (HER2)-negative, hormone receptor-positive (HR+), triple-negative breast cancer (TNBC), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
5دورية أكاديمية
المؤلفون: Ali Darvishi, Rajabali Daroudi, Ali Akbar Fazaeli
المصدر: Health Economics Review, Vol 13, Iss 1, Pp 1-13 (2023)
مصطلحات موضوعية: Cost-utility analysis, Palbociclib, Riboociclib, Letrozole, Metastatic breast cancer, HR+/ HER2, Medicine (General), R5-920
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2191-1991
-
6دورية أكاديمية
المؤلفون: Nar Bahadur Katuwal, Min Sil Kang, Mithun Ghosh, Sa Deok Hong, Yeong Gyu Jeong, Seong Min Park, Seul-Gi Kim, Joohyuk Sohn, Tae Hoen Kim, Yong Wha Moon
المصدر: Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-21 (2023)
مصطلحات موضوعية: CDK4/6, ASO, PEG10, HR+ breast cancer, Drug resistance, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1756-9966
-
7دورية أكاديمية
المؤلفون: Christine Song, Dawa Jung, Ayse Tuba Kendi, Jin Kyung Rho, Eun-Joo Kim, Ian Horn, Geoffry L. Curran, Sujala Ghattamaneni, Ji Yeon Shim, Pil Soo Kang, Daehun Kang, Jay B. Thakkar, Sannidhi Dewan, Val J. Lowe, Seung Baek Lee
المصدر: International Journal of Molecular Sciences, Vol 25, Iss 13, p 7494 (2024)
مصطلحات موضوعية: hormone-receptor-positive (HR+) breast cancer (BC), type 2 diabetes (T2D), forkhead box A1 (FOXA1), metformin, tumor proliferation, metastasis, Biology (General), QH301-705.5, Chemistry, QD1-999
وصف الملف: electronic resource
-
8دورية أكاديمية
المؤلفون: Veruschka Albert, Christina Bruss, Deniz Tümen, Gerhard Piendl, Florian Weber, Edgar Dahl, Stephan Seitz, Olaf Ortmann, Anja K. Wege, Gero Brockhoff
المصدر: International Journal of Molecular Sciences, Vol 25, Iss 13, p 7475 (2024)
مصطلحات موضوعية: hormone receptor positive (HR+) breast cancer, human epidermal growth factor receptor related (HER4), tamoxifen, abemaciclib, humanized tumor mice (HTM), Biology (General), QH301-705.5, Chemistry, QD1-999
وصف الملف: electronic resource
-
9دورية أكاديمية
المؤلفون: Katuwal, Nar Bahadur, Kang, Min Sil, Ghosh, Mithun, Hong, Sa Deok, Jeong, Yeong Gyu, Park, Seong Min, Kim, Seul-Gi, Sohn, Joohyuk, Kim, Tae Hoen, Moon, Yong WhaAff2, IDs1304602302903x_cor10
المصدر: Journal of Experimental & Clinical Cancer Research. 42(1)
-
10دورية أكاديمية
المؤلفون: Darvishi, Ali, Daroudi, Rajabali, Fazaeli, Ali AkbarAff2, Aff3, IDs13561023004636_cor3
المصدر: Health Economics Review. 13(1)